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M embranoproliferative glomerulonephritis (MPGN)is a pattern of injury characterized by mesangial
and endocapillary proliferation, double contours along
the capillary walls, and lobular accentuation of the
capillary tufts.1 Based on pathophysiology, MPGN is
classiﬁed into MPGN mediated by immune complexes
and Igs and complement-mediated MPGN.1,2 Immune
complex/Ig–mediated MPGN most often results from an
underlying infection, autoimmune disease, or mono-
clonal gammopathy.3–5 Complement-mediated MPGN
includes C3 glomerulopathy, which encompasses C3
glomerulonephritis and dense deposit disease.6,7 C3
glomerulopathy is characterized by dominant staining
for C3 and negative or minimal staining for Igs.8 The
staining for C3 is at least 2 orders greater in magnitude
than Ig staining. C3 glomerulopathy results from dys-
regulation of the alternative pathway of complement
with accumulation of complement factors of the alter-
native and terminal pathways of complement.9,10
Infections are an important cause of MPGN that are
usually associated with an immune complex–mediated
MPGN. Immune complex–mediated MPGN due to in-
fections is characterized by the presence of Ig, usually IgG
or IgM, along with complement factors of the classical and
terminal pathways. In this report, we present an unusual
form of MPGN characterized by negative Ig but by large
deposits of complement factors of the classical and terminal
pathways in apatientwith leishmaniasis andHIV infection.
Furthermore,Leishmania species amastigotesweredetected
within macrophages in the interstitium. This ﬁnding of
both complement-mediated MPGN and interstitial inﬂam-
mation associated with leishmaniasis is extremely unusual
and should be kept inmind as an uncommon cause of renal
disease in the immunocompromised host.International Reports (2016) 1, 125–130CASE PRESENTATION
A 35-year-old Hispanic man from El Salvador presented
with abdominal and back pain, proteinuria, and
lower-extremity edema. The patient had a history of
HIV infection with AIDS and leishmaniasis involving
both the skin and bone marrow. The patient was
compliant with HIV treatment and had an undetected
viral load, although his CD4 counts remained low at
75 cells/mm3. He had received treatment for leish-
maniasis with amphotericin B that resulted in
improvement of his cutaneous lesions. The patient also
had pancytopenia with a hematocrit of 21 and neu-
tropenia (white blood cell count 1.8  103/ml and
neutrophil count of 1.5  103/ml). Evaluation of kidney
function revealed a normal serum creatinine of
0.9 mg/dl and signiﬁcant proteinuria of 1.6 g/d. Other
laboratory evaluation included low serum total protein
(5.2 g/dl) and albumin (2.0 g/dl), low hemoglobin
(8.6 g/l), and low platelet count (120  103/ml). The C3
level was low (63 mg/dl, normal range 90–180 mg/dl),
while the C4 level was borderline high (44 mg/dl, normal
range 10–40 mg/dl). Urinalysis showed 2–3þ protein,
with no red blood cells. Remaining evaluation was un-
remarkable with negative serology for antinuclear anti-
body, double-stranded DNA, and hepatitis B and C.
Peripheral blood ﬂow cytometry showed mostly granu-
locytic and monocytic cells positive for CD11c and CD38
and unremarkable lymphocytes with no clonal or
abnormal phenotype. Lymphocytes were composed of
69% T cells with a CD4/CD8 ratio of 1:1. A kidney
biopsy was done to determine the cause of proteinuria.
Kidney Biopsy
The tissue for light microscopy contained 3 cores that
contained 60 glomeruli, of which 13 were globally125
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mesangial and endocapillary hypercellularity, lobular
accentuation of the glomerular capillary tufts, and
double contours along the capillary walls. Interest-
ingly, the capillary walls showed fuscinophilic deposits
on trichrome stains. The deposits had a bead-like
appearance and were particularly prominent on the
toluidine blue stain. No necrotizing, crescentic, or
thrombotic lesions were present. The interstitium
showed patchy interstitial inﬂammation. There was
moderate (30%) tubular atrophy and interstitial ﬁbrosis
(30%) present. Vessels were unremarkable. Most
interestingly, aggregates of macrophages were present
in the interstitium. Numerous Leishmania species
amastigotes were detected in the cytoplasm of macro-
phages; the amastigote kinetoplast was best seen on
Jones methenamine silver stain. Representative light
microscopy ﬁndings are shown in Figure 1a–e.
There were 10 glomeruli present for immunoﬂuo-
rescence microscopy. The glomeruli showed bright
staining for C1q (3þ), C3c (3þ), C3d (3þ), and C4d
(3þ). Surprisingly, staining for Igs was negative.
Immunoﬂuorescence microscopy following pronase
digestion to detect masked Igs showed mild segmental
staining for IgM but was negative for IgA, IgG, and k
and l light chains. Representative immunoﬂuorescence
microscopy ﬁndings are shown in Figure 1f–i.
Electron microscopy showed extremely dense
osmiophilic deposits along the capillary walls and in
the mesangium. Subepithelial, intramembranous, and
subendothelial deposits were all present; the deposits
were large, discrete, and almost bead-like in some
areas. The deposits did not form the sausage-shaped
intramembranous dense deposits seen in dense depo-
sit disease, and substructures were not present.
Electron-dense deposits along the tubular basement
membranes were not present. Representative electron
microscopy ﬁndings are shown in Figure 1j–m.
Kidney Biopsy Diagnosis
Primary Diagnosis
Infection-related glomerulonephritis, with extensive
deposition of complement; leishmaniasis-associated




Focal (22%) global glomerulosclerosis, moderate (30%)
tubular atrophy and interstitial ﬁbrosis.
Laser Microdissection and Mass Spectrometry
We performed laser microdissection of the glomeruli
followed by mass spectrometry to conﬁrm and126determine the complement proﬁle of the deposits.12
Mass spectrometry showed very large spectra
numbers for C3 and C4, moderate spectra numbers for
C9, and smaller spectra numbers for C1q, C5, C6, and
C7. Interestingly, small spectra numbers for IgG1 chain
C region, k chain C region, and Ig l2 C region were also
present. The mass spectrometry proﬁle is shown in
Figure 2.
Clinical Follow-up
The patient was started on monthly infusions of lipo-
somal amphotericin B 200 mg as suppressive therapy
for Leishmania. Since biopsy, his proteinuria has ﬂuc-
tuated based on the timing of the infusions. After
receiving the medication, the proteinuria tends to go
down, but then gradually increases. For example, the
spot albuminuria test on the day of 1 of the infusions
was 3072.3 mg, and 22 days later it was reduced to
1963.2 mg. He has been started on a low dose of lisi-
nopril as well, to be titrated as his blood pressure can
tolerate. His renal function thus far has remained
normal, with serum creatinine of 0.8 mg/dl.
DISCUSSION
Glomerulonephritis in the setting of chronic infections
is typically immune complex–mediated.1,11,13–20 The
kidney biopsy shows immune deposits along with C3
on immunoﬂuorescence studies. The C3 is likely
derived from activation of the classical pathway of
complement by the immune complexes. We describe a
patient with chronic, recurrent leishmaniasis in the
setting of HIV and AIDS who developed glomerulo-
nephritis with numerous deposits of complement fac-
tors of the classical pathway of complement in the
absence of any signiﬁcant immune complexes. In
addition, moderate interstitial inﬂammation was pre-
sent, and Leishmania species amastigotes were detected
within macrophages in the interstitial inﬁltrates.
Amastigotes are generally the only forms of this pro-
tozoal parasite that are seen in humans, and can be
identiﬁed on routine histologic sections by their loca-
tion within macrophages, round–oval shape, small size
(2–4 mm in diameter), and presence of both a nucleus
and a rod-shaped kinetoplast. Amastigotes are not
stained using the Gomori methenamine silver stain for
fungi, and thus can be easily differentiated from
small intracellular yeasts such as Histoplasma capsu-
latum. Notably, the Jones methenamine silver stain
using a hematoxylin and eosin counterstain provided
superior resolution of the kinetoplasts than hematox-
ylin and eosin alone. To our knowledge, this is the
ﬁrst report of using the Jones methenamine silver stain
for enhanced morphologic identiﬁcation of Leishmania
amastigotes.Kidney International Reports (2016) 1, 125–130
Figure 1. Complement-mediated membranoproliferative glomerulonephritis. (a–e) Light microscopy showing a membranoproliferative glomer-
ulonephritis with silver-negative fuscinophilic deposits in the mesangium and along the capillary walls (a, periodic acid–Schiff, original
magniﬁcation X10; b, silver methenamine, original magniﬁcation X40; c, trichrome, original magniﬁcation X60; d, toluidine blue, original
magniﬁcation X60). Note the bead-like deposits along the capillary walls on toluidine blue stain. (e) Leishmania species amastigotes within
tissue macrophages (Jones methenamine silver stain with hematoxylin and eosin counterstain, original magnification X1000). The characteristic
features of the amastigotes, including a small round-to-oval nucleus and rod-shaped kinetoplast (arrow), are shown in the inset (original
magnification approximately X2000). (f–i) Immunofluorescence microscopy showing bright staining for C1q (3þ) (f), C3c (3þ) (g), and C4d 3þ (h),
and negative staining for IgG (i; C3d not shown). (j–m) Electron microscopy showing large and extremely dense deposits in the mesangium and
along the capillary walls. The deposits are subepithelial, intramembranous, and subendothelial. Double contours are noted along the capillary
walls. (j and k, original magnification X4000; l, original magnification X8000; m, original magnification X12,000.)
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Figure 2. Mass spectrometry data show glomerular accumulation of large spectra numbers of C3 and C4. Small spectra numbers for C1q, C6,
C7, and C9 are also present. Small spectra numbers for IgG1 g constant region were also detected. The samples were run in duplicate,
representing 2 separate dissections (samples 1 and 2). Green boxes signify >95% probability for protein identity. The numbers in the boxes
represent the total number of spectra matched to the protein in a sample.
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visceral leishmaniasis. There are only a few reports of
Leishmania species causing renal disease in humans. In
general, leishmaniasis-associated renal disease occurs in
the immunocompromised host, particularly in the
setting of HIV infection. Visceral leishmaniasis treat-
ment failure is common in patients with concomitant
HIV infection, particularly in patients with CD4 counts
below 200 cells/ml as presented here.21 Direct involve-
ment of the renal parenchyma by Leishmania resulting
in interstitial inﬂammation has been reported in the
renal transplant.22 In such cases, Leishmania species
amastigotes are often detected within macrophages (as
noted in our case). Rarely, chronic leishmaniasis may
even be associated with renal AA amyloidosis.23 With
regard to glomerulonephritis, leishmaniasis causes an
immune complex–mediated glomerulonephritis with an
MPGN pattern of injury.24 Most of these cases were
previously reported as MPGN type I or type III, and IgG
and IgM were the commonly detected Igs on immuno-
ﬂuorescence studies.25,26 Cryoglobulins resulting in an
immune complex–mediated glomerulonephritis have
also been reported in the setting of leishmaniasis.27
The kidney biopsy in our case showed many
distinctive ﬁndings. Light microscopy showed an
MPGN pattern of injury that was characterized by
bright staining for C1q and C3 on immunoﬂuorescence
studies indicating activation of the classical pathway of
complement. On immunoﬂuorescence studies there was128no staining for Ig including IgG, IgM, IgA, or k or l
light chains. In order to detect masked Ig deposits, we
performed immunoﬂuorescence studies for IgG, IgA,
IgM, C1q, and k and l light chains following pronase
digestion of the parafﬁn-embedded material (parafﬁn
immunoﬂuorescence), and these studies were also
negative for Ig except for bright staining for C1q.
Thus, both routine and parafﬁn immunoﬂuorescence
studies were negative for Ig deposits. We also per-
formed immunoﬂuorescence studies to detect end
products of C4 and C3 activation by staining for C4d
and C3d, respectively, both of which were brightly
positive. Taken, together the presence of bright C1q,
C4d, C3, and C3d indicates accumulation of the com-
ponents of the classical pathway of complement.
Typically, classical pathway complement factors (C1q,
C3, C4d) are found in the presence of Igs (immune
complex glomerulonephritis).1,26,28 Thus, massive
accumulation of complement factors of classical
pathway of complement in the absence of Igs is un-
usual. Laser microdissection of the glomeruli followed
by mass spectrometry was performed that conﬁrmed
the kidney biopsy ﬁndings.
The ﬁndings are somewhat akin to C3 glomerulop-
athy, where components of the alternative pathway of
complement are present, with the absence or minimal
deposition of Ig.6 C4d, C3d, and C3 deposition may
result from activation of the lectin pathway of com-
plement. However, the ﬁnding of bright C1q alongKidney International Reports (2016) 1, 125–130
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classical pathway and not of the lectin pathway of
complement. The glomerular deposition of a large
amount of complement factors of the classical pathway
and absence of immune deposits are suggestive of
leishmania-driven ﬂuid-phase activation of classical
pathway of complement, similar to that seen in C3
glomerulopathy, where there is ﬂuid-phase activation
of the alternative pathway of complement.29 The lab-
oratory ﬁnding of low C3 levels was consistent with
overall activation of the complement pathway. How-
ever, normal levels of C4 were contrary to the expected
low C4 levels seen in activation of the classical pathway
of complement. It may be related to the activity of the
disease and timing of laboratory tests. However, the
exact cause of this ﬁnding is not known.
The electron microscopy ﬁndings were also unique
in that large extremely dense deposits were present in
the mesangium and along capillary walls. The deposits
were reminiscent of the deposits of dense deposit dis-
ease, except that they did not form the dense intra-
membranous sausage-shaped deposits, but instead
formed bead-like deposits along the capillary walls.
The dense deposits are indicative of deposits composed
of complement factors. Indeed, laser microdissection
and mass spectrometry conﬁrmed the presence of large
spectra for C3 and C4. The high average spectra num-
ber of C3 (average 81) appeared even in excess of those
found in C3 glomerulopathy (average spectra of 33; our
unpublished data). Similarly, large spectra numbers of
C4 were present. Finally, the presence of C6, C7, and C9
indicated terminal pathway of complement activation.
Small spectra numbers of IgG (average 5) were detected
on mass spectrometry. However, it is difﬁcult to draw
meaningful conclusions of low spectra numbers since
small spectra for IgG may be derived from the plasma
in the glomeruli.
A search of the literature revealed a case similar to
our case in which the authors described a 47-year-old
man with HIV and leishmaniasis.29 The kidney biopsy
showed an MPGN pattern of injury, and the immu-
noﬂuorescence was characterized by bright C3 and
C1q, and negative Igs. Electron microscopy was not
reported.
Interestingly, treatment of Leishmania with monthly
infusions of amphotericin resulted in a decrease in
proteinuria, which gradually increased again prior to
the next infusion. It was felt that the amphotericin
infusions may control the Leishmania infection but not
cure the leishmaniasis. The ﬂuctuation in proteinuria
supports the ﬁnding that the glomerulonephritis is
directly linked to the leishmaniasis. Leishmania avidly
weakens the T helper cell 1 host immune response
through mediation of cytokine secretion. HIV infectionKidney International Reports (2016) 1, 125–130has a similar effect on the T helper 1 cellular immune
response and promotes transition to a T helper cell 2
response, resulting in decreased macrophage anti-
leishmanial activity. HIV and Leishmania coinfection
results in a greatly elevated risk of recurrent visceral
leishmaniasis and progression to AIDS.30 The massive
complement accumulation may result from decreased
macrophage activity and weakened T helper cell 1
response resulting in defective clearing mechanisms.
CONCLUSION
To summarize, we present an unusual form of
glomerulonephritis characterized by the presence of
large amounts of complement factors of the classical
pathway of complement and extremely dense deposits
in the mesangium and along the capillary walls in the
setting of HIV infection and leishmaniasis. Further-
more, we detected Leishmania species amastigotes
within macrophages in the interstitium using routine
hematoxylin and eosin and Jones silver stains.
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